The treatment of osteoarthritis with new injectable cells may be successful.

Published Date: 26 Apr 2023

Researchers from the Wake Forest Institute for Regenerative Medicine (WFIRM) have developed a promising injectable cell therapy for osteoarthritis that not only lowers inflammation but also regenerates articular cartilage.

Read Full News

Latest News

OA Trial Drug Seeks to Be Analgesic Alternative to NSAIDs

If future trials continue to show positive results, the drug may provide a pain-relief option that lacks the risks of long-term NSAID use.

10-Year Data Confirm No Benefit From Knee Arthroscopy

Ten-year follow-up data from the FIDELITY sham knee arthroscopy study confirms the procedure offers no benefits and may be associated with worse outcomes.

PT Beats CBT for First-Line Low Back Pain Treatment

Findings of a real-world study confirm guidelines that recommend physical therapy as first-line treatment; it has a slight edge over cognitive-behavioral therapy.

Do Palindromic Flares Indicate Future Arthritis Joint Sites?

Palindromic rheumatism often begins with hand and shoulder involvement, and patients who progress to persistent inflammatory arthritis develop it in joints affected by prior palindromic flares.

Prescribing Walks Wisely in Low Back Pain

Individualized walking programs can reduce recurrent, disabling low back pain, but clinicians should screen for lower extremity biomechanical vulnerabilities and favor low impact options when needed.

Winter Sports and Lower Limb Motor Disability

People with lower limb motor disability need tailored equipment, training, and medical oversight to boost performance while preventing upper limb overload and skin problems.

Todays Updates

How Doctors Can Thrive in a World of Constant Interruption

A steady deluge of interruptions, demands, and distractions drain physicians and raise the risk of errors. Here’s how to protect your focus.

Study Finds Microplastics Near Tumors; Experts Doubt Results

Using LDIR, O PTIR, Py GC/MS, and SEM, researchers quantified MNPs in 191 brain samples, but experts question the unusually high particle masses and urge methodological validation.

Todays Updates

How Doctors Can Thrive in a World of Constant Interruption

A steady deluge of interruptions, demands, and distractions drain physicians and raise the risk of errors. Here’s how to protect your focus.

Study Finds Microplastics Near Tumors; Experts Doubt Results

Using LDIR, O PTIR, Py GC/MS, and SEM, researchers quantified MNPs in 191 brain samples, but experts question the unusually high particle masses and urge methodological validation.

Latest News

If future trials continue to show positive results, the drug may provide a pain-relief option that lacks the risks of long-term NSAID use.

Ten-year follow-up data from the FIDELITY sham knee arthroscopy study confirms the procedure offers no benefits and may be associated with worse outcomes.

Findings of a real-world study confirm guidelines that recommend physical therapy as first-line treatment; it has a slight edge over cognitive-behavioral therapy.

Palindromic rheumatism often begins with hand and shoulder involvement, and patients who progress to persistent inflammatory arthritis develop it in joints affected by prior palindromic flares.

Individualized walking programs can reduce recurrent, disabling low back pain, but clinicians should screen for lower extremity biomechanical vulnerabilities and favor low impact options when needed.

People with lower limb motor disability need tailored equipment, training, and medical oversight to boost performance while preventing upper limb overload and skin problems.

News All Time

Walking, cycling and swimming are likely the best exercises for knee osteoarthritis

For patients with knee osteoarthritis, aerobic activities such as walking, cycling, or swimming are likely to be the best exercise for improving pain, function, gait performance, and quality of life, finds a study published ...

SGLT-2 diabetes drugs linked to lower risk of autoimmune diseases

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of autoimmune rheumatic diseases, such as rheumatoid arthritis and lupus, compared with another group ...

Arthritis pain rising: How state policies matter

New research from The University of Texas at Arlington shows that differences in state welfare policies are linked to rising arthritis-related joint pain across much of the U.S.

Customizable finger brace toggles between stiff and flexible for easier recovery

A friend's struggles with arthritis and the finger braces used to manage it inspired research by a Carnegie Mellon University student that could make it easier for patients to follow rehabilitation plans, speed up recovery ...

AI predicts future X-rays to help osteoarthritis patients and their doctors see what's coming

An AI system that can predict what a patient's knee X-ray will look like a year in the future could transform how millions of people with osteoarthritis understand and manage their condition, according to research by the ...

Joint pain or osteoarthritis? Exercise could be the first line of treatment

Stiff knees, aching hips and the slow grind of chronic joint pain are often accepted as an unavoidable part of getting older. But while osteoarthritis is the world's most common joint disease, experts say the way we treat ...

Study finds tailored exercise program feasible for adults over 80 with osteoarthritis

A new NDORMS study has found that a tailored exercise program for people aged 80 years and older with hip and/or knee osteoarthritis and other long term health conditions is both practical and acceptable, paving the way for ...

New treatment for psoriatic arthritis shows promising results in early trial

A new treatment for a debilitating inflammatory condition which affects joints and skin has shown promising early results in an international clinical trial of more than 200 patients worldwide.

Seven-year study reveals rheumatoid arthritis begins long before symptoms, opening door to prevention 

Scientists have discovered that rheumatoid arthritis (RA) doesn't start when the pain begins. It silently starts years earlier. RA is a debilitating autoimmune disease that causes painful joint inflammation and damage. The ...

Self-guided online program improves quality of life in rheumatoid arthritis, psoriatic arthritis and lupus

Patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus frequently face anxiety and depression along with chronic physical symptoms. Reported rates of depression range from 15% to 24% and ...

Analysis isolates population aging as primary driver of musculoskeletal disorders

Novel research shows that in approximately one third of countries and territories worldwide, population aging was the largest contributor to the growing burden of musculoskeletal disorders from 1990 to 2021.

Tirzepatide found to be more cost-effective than semaglutide in patients with knee osteoarthritis, obesity

A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs), semaglutide and tirzepatide, for patients with osteoarthritis and obesity compared with usual ...

Current research may open doors to new treatments for children with juvenile dermatomyositis

Children with a rare, debilitating muscle disease could benefit from the findings of new research by experts at UCL and Great Ormond Street Hospital (GOSH).

Squishy 'smart cartilage' could target arthritis pain as soon as flareups begin

Researchers have developed a material that can sense tiny changes within the body, such as during an arthritis flareup, and release drugs exactly where and when they are needed.

Immune aging may be a driver of rheumatoid arthritis rather than a consequence

Features of immune system aging can be detected in the earliest stages of rheumatoid arthritis (RA), even before clinical diagnosis, a new study has found which provides at-risk individuals with hope for early intervention.

Common arthritis drug found to lower blood pressure and risk of heart disease

Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognized useful secondary effect of lowering blood pressure and potentially reduces the risk of heart disease in people with this condition.

Recommended News For You

AI tool identifies women at high risk of interval breast cancer

Pancreatic cancer RNA vaccine shows durable T cell immunity

Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

A better option for mild to moderate depression?

In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.

Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation

Recommended Articles For You

The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective 

A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia 

Unveiling the Mystery of Epstein-Barr Virus: What We Know So Far 

Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

ALK Inhibitor Shows Promise in Rare, Progressive Tumor Types

2.

The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.

3.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

4.

Reducing social media to an hour a day boosts young people's self-image.

5.

Charles III, King of Kings, is Cancerous.

1.

What You Need To Know About Trametinib: A Miracle Cancer Treatment?

2.

Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches

3.

Revolutionizing Cancer Treatment: Harnessing the Power of AI in Histopathology

4.

Management of Relapsed Synovial Sarcoma: Current Treatment Strategies and Emerging Therapies

5.

Unlocking the Potential of Leukemia Treatment: A New Hope for Patients

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Thromboprophylaxis In Medical Settings

2.

Navigating the Complexities of Ph Negative ALL - Part II

3.

A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

4.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot